一次性静脉输液治疗产品市场
一次性静脉输液治疗产品市场：2026年市场规模约为237.9亿美元，2031年市场规模约为310.9亿美元；预测期复合年增长率为5.50%；当前最大市场为北美；增长最快的市场为亚太地区。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
一次性静脉输液治疗产品市场：2026年市场规模约为237.9亿美元，2031年市场规模约为310.9亿美元；预测期复合年增长率为5.50%；当前最大市场为北美；增长最快的市场为亚太地区。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 5.5% | 机构预测 |
| 市场规模 | 2026 | USD 23.79 billion | 机构预测 |
| 市场规模 | 2031 | USD 31.09 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| application | medication administration | 2025 | 34.890% |
| end_user | hospitals | 2025 | 55.670% |
| geography | North America | 2025 | 40.560% |
| product_type | IV catheters and cannulas | 2025 | 45.670% |
| usability | disposable and single-use products | 2025 | 76.550% |
关键结论
- application 维度中，medication administration 在 2025 年的公开份额为 34.89%。
- end_user 维度中，hospitals 在 2025 年的公开份额为 55.67%。
- geography 维度中，North America 在 2025 年的公开份额为 40.56%。
- product_type 维度中，IV catheters and cannulas 在 2025 年的公开份额为 45.67%。
- usability 维度中，disposable and single-use products 在 2025 年的公开份额为 76.55%。
主要参与者
- B. Braun Melsungen SE
- Baxter International Inc.
- Becton, Dickinson and Company
- Fresenius SE & Co. KGaA
- Terumo Corporation
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Rising IV medication and nutrition use | +1.400% | Global, with a pronounced effect in North America, Europe, and the Asia-Pacific | Medium term (2-4 years) |
| Chronic disease, surgery, and critical care growth | +1.200% | Global, with the highest volume effect in North America, Europe, and China | Long term (≥ 4 years) |
| Home and ambulatory infusion care expansion | +0.900% | North America and Europe, with expansion into Asia-Pacific, the Middle East, and Africa | Medium term (2-4 years) |
| Dedicated set demand from installed infusion pumps | +0.700% | Global, concentrated in hospital upgrade markets in North America and East Asia | Short term (≤ 2 years) |
| Needleless access and infection prevention requirements | +0.800% | North America and the European Union, with increasing relevance in the Asia-Pacific | Medium term (2-4 years) |
| Closed-loop traceability of sets, drugs, and patient identity | +0.500% | North America and highly digitized European markets | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Tendering and volume-based procurement pressure | -0.800% | Global, with the sharpest effect in Europe, China, and government-led payer systems | Short term (≤ 2 years) |
| Material, sterility, and chemical compatibility qualification burden | -0.500% | Global, particularly for newer entrants using North American and European Union pathways | Medium term (2-4 years) |
| PVC, DEHP, and other material restriction risk | -0.400% | European Union, with relevance spreading to the United Kingdom, Australia, and the Asia-Pacific | Long term (≥ 4 years) |
| Procedure volume, volatility, and hospital inventory destocking | -0.300% | North America, with periodic effects in markets exposed to natural disasters and supply shocks | Short term (≤ 2 years) |
报告关注的关键问题
What is the expected growth rate for disposable hospital gowns?
The disposable hospital gowns market is forecast to grow at a 12.66% CAGR from 2026 to 2031, increasing from USD 2.88 billion in 2026 to USD 4.23 billion in 2031.
Which product category leads global revenue?
Surgical gowns led revenue with a 49.88% share in 2025 because they are used across high-acuity operating room procedures.
Which gown category is expected to grow fastest?
Chemotherapy gowns are forecast to grow at a 14.52% CAGR through 2031, supported by hazardous-drug handling requirements.
Why are sterile disposable gowns important?
Sterile disposable gowns held 64.67% of revenue in 2025 and are used where aseptic conditions and stronger barrier protection are required.
What is driving demand from ambulatory surgery centers?
ASCs are expected to grow at a 13.87% CAGR through 2031 as additional higher-acuity procedures become eligible for outpatient treatment.
Which region is growing fastest?
Asia-Pacific is forecast to grow at a 14.77% CAGR during 2026 to 2031, supported by hospital expansion and growing local manufacturing capacity.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence